Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer.
In: BMJ: British Medical Journal, Jg. 352 (2016-02-06), Heft 8043, S. i262
Online
academicJournal
Zugriff:
The article examines the risks involved in squamous cell cancer and basal cell cancer in patients with rheumatoid arthritis susceptible to biologic drugs. Topics discussed include the efficiency and impact of tumour necrosis factor inhibitor treatment, comparison of results between biologics-naive patients and the general population, and the importance of being vigilant on skin malignancies in patients with rheumatoid arthritis.
Titel: |
Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer.
|
---|---|
Link: | |
Zeitschrift: | BMJ: British Medical Journal, Jg. 352 (2016-02-06), Heft 8043, S. i262 |
Veröffentlichung: | 2016 |
Medientyp: | academicJournal |
ISSN: | 1756-1833 (print) |
DOI: | 10.1136/bmj.i262 |
Schlagwort: |
|
Sonstiges: |
|